Multisite phosphorylation and the integration of stress signals at p53.
暂无分享,去创建一个
[1] D. Meek,et al. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. , 1992, Oncogene.
[2] C. Prives,et al. Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminus , 1995, Cell.
[3] G. Chu,et al. DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. , 1997, Cancer research.
[4] C. Miller,et al. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription , 1993, Molecular and cellular biology.
[5] W. Deppert,et al. Negative feedback regulation of wild‐type p53 biosynthesis. , 1995 .
[6] R. Carroll,et al. Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[8] D. Virshup,et al. Control of simian virus 40 DNA replication by the HeLa cell nuclear kinase casein kinase I , 1993, Molecular and cellular biology.
[9] P. Shaw,et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] V. Rotter,et al. Accumulation of wild‐type p53 protein upon gamma‐irradiation induces a G2 arrest‐dependent immunoglobulin kappa light chain gene expression. , 1995, The EMBO journal.
[11] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[12] Peter A. Hall,et al. EDITORIAL. p53—INTEGRATING THE COMPLEXITY , 1996 .
[13] C. Finlay,et al. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth , 1993, Molecular and cellular biology.
[14] E. Winchester,et al. Inhibition of DNA replication factor RPA by p53 , 1993, Nature.
[15] C. Prives,et al. Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases , 1995, Nature.
[16] C. Slaughter,et al. Purification of casein kinase I and isolation of cDNAs encoding multiple casein kinase I-like enzymes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Levine,et al. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells , 1979, Cell.
[18] M. Hoekstra,et al. Characterization of two protein kinases from Schizosaccharomyces pombe involved in the regulation of DNA repair. , 1994, The EMBO journal.
[19] C. Delphin,et al. Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation. , 1992, The Journal of biological chemistry.
[20] A. Levine,et al. Regulation of Transcription Functions of the p53 Tumor Suppressor by the mdm-2 Oncogene , 1995, Molecular medicine.
[21] D. Meek,et al. Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53. , 1992, Nucleic acids research.
[22] U. Knippschild,et al. p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. , 1996, Oncogene.
[23] U. Knippschild,et al. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs , 1997, Oncogene.
[24] C. Marshall,et al. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.
[25] G. Landes,et al. Isolation and Characterization of Human Casein Kinase Iε (CKI), a Novel Member of the CKI Gene Family (*) , 1995, The Journal of Biological Chemistry.
[26] P. Jeggo,et al. DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] P. Cohen,et al. The search for physiological substrates of MAP and SAP kinases in mammalian cells. , 1997, Trends in cell biology.
[28] G. Lozano,et al. Analysis of p53 mutants for transcriptional activity , 1991, Molecular and cellular biology.
[29] X. Chen,et al. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. , 1993, Genes & development.
[30] D. Lane. A death in the life of p53 , 1993, Nature.
[31] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[32] D. Lane,et al. Activation of the cryptic DNA binding function of mutant forms of p53. , 1993, Nucleic acids research.
[33] C. Sunkel,et al. The casein kinase 1 alpha gene of Drosophila melanogaster is developmentally regulated and the kinase activity of the protein induced by DNA damage. , 1996, Journal of cell science.
[34] U. Ramsperger,et al. p53‐catalyzed annealing of complementary single‐stranded nucleic acids. , 1993, The EMBO journal.
[35] P. Branton,et al. Regulation of apoptosis by viral gene products , 1997, Journal of virology.
[36] I. Takenaka,et al. Regulation of the Sequence-specific DNA Binding Function of p53 by Protein Kinase C and Protein Phosphatases (*) , 1995, The Journal of Biological Chemistry.
[37] K. Scheidtmann,et al. Phosphorylation studies on rat p53 using the baculovirus expression system. Manipulation of the phosphorylation state with okadaic acid and influence on DNA binding. , 1995, European journal of biochemistry.
[38] F. Heffron,et al. HRR25, a putative protein kinase from budding yeast: association with repair of damaged DNA , 1991, Science.
[39] P. Friedman,et al. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[40] W Eckhart,et al. Phosphorylation sites in the amino-terminal region of mouse p53. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Lord,et al. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate. , 1996, Oncogene.
[42] L. Donehower,et al. p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. , 1996, Genes & development.
[43] C. Anderson. Protein kinases and the response to DNA damage. , 1994, Seminars in cell biology.
[44] S. Jackson,et al. The role of Ataxia telangiectasia and the DNA-dependent protein kinase in the p53-mediated cellular response to ionising radiation. , 1996, Oncogene.
[45] C. Prives,et al. p53: puzzle and paradigm. , 1996, Genes & development.
[46] J. Lord,et al. Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. , 1997, Molecular pathology : MP.
[47] A. Levine,et al. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[48] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[49] R. Weinberg,et al. Cell-cycle control and its watchman , 1996, Nature.
[50] M. Kastan,et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Oren,et al. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. , 1993, Oncogene.
[52] K. Kinzler,et al. Life (and death) in a malignant tumour , 1996, Nature.
[53] Carissa A. Sanchez,et al. A p53-dependent mouse spindle checkpoint , 1995, Science.
[54] D. Meek,et al. Phosphorylation of p53 in normal and simian virus 40-transformed NIH 3T3 cells , 1988, Molecular and cellular biology.
[55] M. Evans,et al. p53 modulation of TFIIH–associated nucleotide excision repair activity , 1995, Nature Genetics.
[56] M. Oren,et al. p53 in growth control and neoplasia. , 1996, Biochimica et biophysica acta.
[57] C. Anderson,et al. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen , 1990, Molecular and cellular biology.
[58] S. D. Gross,et al. Cell cycle-dependent localization of casein kinase I to mitotic spindles. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[59] L. Szekely,et al. p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. , 1995, Nucleic acids research.
[60] K. Scheidtmann,et al. p53 phosphorylation mutants retain transcription activity. , 1995, Oncogene.
[61] R. Tjian,et al. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. , 1995, Science.
[62] D. Meek,et al. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. , 1990, The EMBO journal.
[63] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[64] M. Fiscella,et al. Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[65] D. Lane,et al. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. , 1994, Cold Spring Harbor symposia on quantitative biology.
[66] D. Meek. Post-translational modification of p53. , 1994, Seminars in cancer biology.
[67] D. Meek,et al. Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases. , 1994, The Journal of biological chemistry.
[68] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[69] P. Jeggo,et al. DNA double-strand break repair and V(D)J recombination: involvement of DNA-PK. , 1995, Trends in biochemical sciences.
[70] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[71] J. Danska,et al. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. , 1996, Genes & development.
[72] M. Kapoor,et al. Mutation of Phosphoserine 389 Affects p53 Function in Vivo* , 1996, The Journal of Biological Chemistry.
[73] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[74] M. Subler,et al. p53 binds to the TATA-binding protein-TATA complex. , 1993, The Journal of biological chemistry.
[75] M. Lohrum,et al. Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. , 1996, Oncogene.
[76] T. Soussi,et al. Structural aspects of the p53 protein in relation to gene evolution: a second look. , 1996, Journal of molecular biology.
[77] D. Meek,et al. p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1 (*) , 1995, The Journal of Biological Chemistry.
[78] M. Fiscella,et al. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. , 1994, Oncogene.
[79] S. Jackson,et al. The recognition of DNA damage. , 1996, Current opinion in genetics & development.
[80] D. Grunwald,et al. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[81] D. Meek,et al. Phosphorylation of p53 at the casein kinase II site selectively regulates p53-dependent transcriptional repression but not transactivation. , 1996, Nucleic acids research.
[82] D. Lane,et al. Two Distinct Signaling Pathways Activate the Latent DNA Binding Function of p53 in a Casein Kinase II-independent Manner (*) , 1995, Journal of Biological Chemistry.
[83] D. Lane,et al. T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.
[84] T. Crook,et al. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function. , 1994, Oncogene.
[85] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[86] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.
[87] A. Levine,et al. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches , 1995, Cell.
[88] C. Delphin,et al. The protein kinase C activator, phorbol ester, cooperates with the wild-type p53 species of Ras-transformed embryo fibroblasts growth arrest. , 1994, The Journal of biological chemistry.
[89] M. Botchan,et al. The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication , 1993, Cell.
[90] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[91] C. Hagedorn,et al. Molecular cloning, expression, and characterization of a 49-kilodalton casein kinase I isoform from rat testis. , 1993, The Journal of biological chemistry.
[92] Y. Tan,et al. Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. , 1992, The Journal of biological chemistry.
[93] F. Alt,et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation , 1995, Cell.
[94] D. Ward,et al. Gene for the catalytic subunit of the human DNA-activated protein kinase maps to the site of the XRCC7 gene on chromosome 8. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[95] M. Montenarh,et al. Association of casein kinase II with immunopurified p53. , 1991, Oncogene.
[96] R. Pepperkok,et al. Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle. , 1994, The Journal of biological chemistry.
[97] S. Fields,et al. Presence of a potent transcription activating sequence in the p53 protein. , 1990, Science.
[98] Bert Vogelstein,et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.
[99] L. Tack,et al. Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection , 1992, Journal of virology.
[100] T. Jacks,et al. Mutations in the p53 and SCID genes cooperate in tumorigenesis. , 1996, Genes & development.
[101] E. Appella,et al. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells. , 1992, Oncogene.
[102] A. Levine,et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.
[103] C. Ingles,et al. The transactivator proteins VP16 and GAL4 bind replication factor A , 1993, Cell.
[104] A. Levine,et al. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[105] K. Vousden,et al. Transcriptional activation by p53 correlates with suppression of growth but not transformation , 1994, Cell.
[106] A. Kimchi,et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.
[107] S. E. Lee,et al. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle , 1997, Molecular and cellular biology.
[108] C. Anderson,et al. DNA damage and the DNA-activated protein kinase. , 1993, Trends in biochemical sciences.